SMS Pharmaceuticals Ltd Share Price

Q: What is the share price of SMS Pharmaceuticals Ltd today?

SMS Pharmaceuticals Ltd share price as on 12 Jun 2026 is ₹386.05

Pharmaceuticals

NSE: SMSPHARMA Small Cap ISIN: INE812G01025

As on 13 June 2026 at 03:48 IST

₹386.05

+ 6.85

(1.81%)

Sell Buy

Over 1 Month

-9.57%

Over 6 Months

18.17%

Over 1 Year

47.35%

Over 3 Years

311.28%

SMS Pharmaceuticals Ltd Summary

Close ₹379.20

Open ₹380.35

High ₹386.15

Low ₹376.30

Volume 1,27,947

Net Turnover (in Cr) ₹4.88

52Wk High ₹447.80

52Wk Low ₹207.70

52Wk High / Low

207.70

447.80

SMS Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹3,551.28

EPS (TTM) 9.35

Book Value (BV) 85.93

Div. Yield 0.11 %

P/E (TTM) 40.63

Price/Book Value 4.42

Delivery % 43.03 %

Face Value 1

Key Ratios

PE Ratio 27.59

PB Ratio 2.87

EV to Sales 2.75

PEG Ratio 0.86

ROA 6.94

ROE 11

Debt-Equity 0.48

Net Profit Margin 8.18

Operating Profit Margin 17.50

SMS Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	788.97	713.72	526.97	525.07	566.63
Total Expenses	696.63	647.62	521.62	456.57	475.51
Profit Before Tax	92.34	66.11	5.35	68.50	91.12
Profit After Tax	67.40	49.20	3.88	67.88	60.96
Operating Profit After Depreciation	110.88	89.56	27.26	87.37	102.28

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	532.98	437.26	412.02	437.99	457.36
Total Non Current Assets	598.21	500.20	468.96	482.45	502.88
Total Current Assets	554.47	533.89	410.65	377.05	309.33
Total Assets	1,152.68	1,034.09	879.61	859.50	812.21
Total Shareholder's Fund	639.64	536.33	460.53	470.29	410.53

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	81.71	50.12	22.45	45.06	90.45
Net Cash Used In Investing Activities	-123.43	-52.07	-29.76	-27.15	-151.59
Net Cash Used In Financing Activities	47.08	30.68	-31.97	-11.75	92.02

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	788.97	713.72	526.97	525.07	566.63
Total Expenses	695.65	647.39	521.42	456.42	475.51
Profit Before Tax	93.32	66.33	5.55	68.65	91.12
Profit After Tax	68.38	49.42	4.08	68.04	60.96
Operating Profit After Depreciation	111.86	89.79	27.46	87.53	102.28

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	532.98	437.26	412.02	437.99	457.36
Total Non Current Assets	631.64	534.36	503.54	505.92	520.58
Total Current Assets	554.46	533.89	410.65	377.05	309.33
Total Assets	1,186.10	1,068.25	914.18	882.97	829.91
Total Shareholder's Fund	673.07	570.49	495.10	493.76	428.22

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	81.71	50.12	22.45	45.06	90.45
Net Cash Used In Investing Activities	-123.44	-52.07	-29.76	-27.15	-151.59
Net Cash Used In Financing Activities	47.08	30.68	-31.97	-11.75	92.02

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	237.95	210.45	242.43	196.05	248.20
Total Expenses	198.05	166.80	194.07	156.68	207.39
Profit Before Tax	27.06	31.16	34.03	24.37	28.52
Profit After Tax	20.96	23.19	25.13	18.71	20.08
Operating Profit after Depreciation	42.47	47.40	49.79	39.96	42.23

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	237.95	210.45	242.43	196.05	248.20
Total Expenses	198.07	166.65	194.05	157.19	206.85
Profit Before Tax	27.04	31.31	34.05	23.86	29.06
Profit After Tax	20.92	23.34	25.14	18.21	20.62
Operating Profit after Depreciation	42.45	47.55	49.81	39.45	42.77

SMS Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 374.95

S2 370.70

S3 365.10

Pivot 380.55

R1 384.80

R2 390.40

R3 394.65

Moving Average

20 SMA 382.07

50 SMA 397.07

100 SMA 374.32

200 SMA 330.93

SMS Pharmaceuticals Ltd Corporate Actions

SMS Pharmaceuticals Ltd

₹0.4/Share

Announcement Date 22 Sep 2025

Record Date 22 Sep 2025

Div Yield 40%

AGM Date: 30 Sep 2021

With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held on today, inter-alia considered and approved the following: Convening the 33rd Annual General Meeting on 30th, September, 2021 With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held on today, inter-alia considered and approved the following: 1. Approved the Standalone and Consolidated Un-audited Financial Results for the Quarter ended 30th June, 2021 along with the Limited Review Report 2. Reclassification of promoter group shareholding from promoter category to public category. 3. Directors Report by the Board for the FY 2020-21 4. Convening the 33rd Annual General Meeting on 30th, September, 2021 5. Dividend Distribution Policy With reference to the above cited subject, in continuation to our letter dated 4th September, 2021 regarding the calendar events, we would like to bring to the notice of all the stakeholders the revised event calendar regarding the change in cut-off date from 17th September, 2021 to 21st September, 2021(i.e cutoff date 21st September, 2021) related to the 33rd Annual General Meeting (AGM) of the Company to be held on Thursday, September 30, 2021 through Video Conferencing/ OAVM: (As per BSE Announcement Dated on 7/9/2021) Summary of proceedings of 33rd Annual General Meeting (AGM) of the Company - Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. (As Per BSE Announcement Dated on 9/30/2021 11:31:36 AM The 33rd Annual General Meeting (AGM) of the Company was held on 30th September, 2021 at 09.00 A.M. at the Registered Office of the Company Situated at Plot.No: 72, H.No: 8-2-334/3&4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad 500034. 1. In accordance with the Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, with reference to all the items of the business contained in the AGM Notice dated 8th September, 2021 were transacted and approved by the members with requisite majority. 2. Report of the Scrutinizer dated 30th September, 2021, pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4)(xii) of the Companies (Management and Administration) Rules, 2015 is annexed. (As Per BSE announcement Dated on 01.10.2021)

AGM Date: 30 Sep 2022

AGM 30/09/2022 Fixation of AGM date, Book Closure and Record Date for AGM (As Per BSE Announcement Dated on 13/08/2022) Proceedings of Annual General Meeting held on 30-Sep-2022 (As Per BSE Announcement dated on 30.09.2022)

AGM Date: 30 Sep 2023

Outcome of Board Meeting and Financial Results Submission of NEWS Paper Publication regarding the 35 AGM held through VC/OAVM. (As Per BSE Announcement Dated on 04.09.2023) Summary Proceedings of 35th Annual General Meeting (As Per BSE Announcement dated on 30.09.2023)

AGM Date: 30 Sep 2024

AGM 30/09/2024 Voting Results of 36th Annual General Meeting (As per BSE Announcement Dated on 1/10/2024)

AGM Date: 29 Sep 2025

Outcome of Board Meeting and Financial Results for the first quarter ended 30th June, 2025 Summary proceedings of the 37th AGM of the Company (As Per BSE Announcement Dated on: 29/09/2025)

SMS Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

SMS Pharmaceuticals Ltd Top Mutal Funds Invested

Fund Name	AUM
Quant Healthcare Fund	7.66%
Quant Small Cap Fund	0.22%
Bandhan BSE Healthcare Index Fund	0.07%

SMS Pharmaceuticals Ltd News

Board of SMS Pharmaceuticals recommends final dividend

Of Rs 0.4 per share

22 May 2026, 07:28 pm

SMS Pharmaceuticals announces board meeting date

On 22 May 2026

18 May 2026, 03:14 pm

SMS Pharma edges higher after Q3 PAT rises nearly 29% YoY

SMS Pharmaceuticals added 1.44% to Rs 320.55 after the company reported 28.7% jump in consolidated net profit to Rs 23.47 crore on a 21.4% increase in net sales to Rs 210.45 crore in Q3 FY26 as compared with Q3 FY25.

09 Feb 2026, 10:16 am

SMS Pharmaceuticals to announce Quarterly Result

On 7 February 2026

01 Feb 2026, 10:18 am

SMS Pharmaceuticals incorporates WoS named - SMS coLab

24 Dec 2025, 12:46 pm

SMS Pharmaceuticals Ltd Stock Analysis

Annual revenue for SMS Pharmaceuticals Ltd increased by 10.54% to ₹788.97 crore in FY 2025 from ₹713.72 crore in FY 2024.
Annual Net Profit for SMS Pharmaceuticals Ltd increased by 38.35% to ₹68.38 crore in FY 2025 from ₹49.42 crore in FY 2024.
Promoter Shareholding in SMS Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 68.07% in December 2025 to 68.07% in March 2026.
SMS Pharmaceuticals Ltd delivered a 1-year return of 47.35% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
SMS Pharmaceuticals Ltd share price moved up by 1.81% from its previous close of INR ₹379.20. The latest SMS Pharmaceuticals Ltd share price is INR ₹386.05.
SMS Pharmaceuticals Ltd share price today has been at a low of 382.10 and a high of 389.70. Over the past 52 weeks, the SMS Pharmaceuticals Ltd share price has seen a low of 207.70 and a high of 447.80.